This month’s Drug Discovery Today Editor’s Choice newsletter is concerned with the field of ADME-Tox. We are highlighting aspects of this rapidly-expanding discipline with some recently published reviews from the pages of Drug Discovery Today.
31 May, 2011
ELRIG are pleased to announce that Dr Jamie Thomson, Wisconsin University, one of the world’s leading experts in stem cell biology, has been confirmed as one of the Keynote Speakers for this conference.
31 May, 2011
A University of Edinburgh based start-up company has created the world’s first 3D hologram based on the properties of a Nobel Prize winning scientific discovery, which enhances biomedical research into the behavioural activity of proteins.
26 May, 2011
The ELRIG meeting on High Throughput BioProcess development is only a few weeks away.
25 May, 2011
Cancer Research UK scientists have discovered that a common gene fault in cervical cancer cells triggers a ripple of molecular signals, which makes the disease more aggressive, according to research published in The Journal of Pathology.
18 May, 2011
A pioneering investigation into the treatment of cervical cancer will take place at the University of Leeds following a major advancement in the study of the disease.
17 May, 2011
Today sees the launch of Palexia® SR (tapentadol prolonged release) for the oral treatment of adults with severe chronic pain, which can only be adequately managed with opioid analgesics. Palexia® SR is the first in a new class of centrally acting analgesics called MOR-NRI, which has two mechanisms of action in one molecule; both µ-opioid receptor (MOR) agonism and noradrenaline reuptake inhibition (NRI).
16 May, 2011
A new, promising marker for diagnosing prostate cancer has been discovered by Uppsala researchers with the aid of a unique method developed at the Department of Immunology, Genetics and Pathology. The study, being published this week in the journal Proceedings of the National Academy of Sciences, PNAS, can lead to more reliable diagnoses and fewer unnecessary operations.
11 May, 2011
Professor Sir Michael Rawlins, the current Chairman of NICE (the National Institute for Health and Clinical Excellence) has been elected as the next President of the Royal Society of Medicine.
06 May, 2011
A rarely prescribed asthma drug is easier to use and just as effective as conventional treatment with inhalers, according to a new study led by the University of East Anglia (UEA).
05 May, 2011
Although drug delivery may not attract the attention and press coverage of some of the other disciplines involved in drug discovery, it is equally important in the development of a successful product. Effective drug delivery can be the difference between getting a molecule into clinical trial rather than a chemical sitting in a brown bottle on the shelf, or a forgotten compound languishing in a 96 well storage plate. It can mean the difference between a drug that just wipes its feet in the market and the discovery of a blockbuster.
05 May, 2011